Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Aug 1;2(8):a006239.
doi: 10.1101/cshperspect.a006239.

Epidemiology of Alzheimer disease

Affiliations
Review

Epidemiology of Alzheimer disease

Richard Mayeux et al. Cold Spring Harb Perspect Med. .

Abstract

The global prevalence of dementia has been estimated to be as high as 24 million, and is predicted to double every 20 years until at least 2040. As the population worldwide continues to age, the number of individuals at risk will also increase, particularly among the very old. Alzheimer disease is the leading cause of dementia beginning with impaired memory. The neuropathological hallmarks of Alzheimer disease include diffuse and neuritic extracellular amyloid plaques in brain that are frequently surrounded by dystrophic neurites and intraneuronal neurofibrillary tangles. The etiology of Alzheimer disease remains unclear, but it is likely to be the result of both genetic and environmental factors. In this review we discuss the prevalence and incidence rates, the established environmental risk factors, and the protective factors, and briefly review genetic variants predisposing to disease.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The annual incidence rate (per 100 person-years) for Alzheimer disease. This graph is an estimate of the data collected in 24 published studies.

Similar articles

Cited by

References

    1. Aevarsson O, Skoog I 1996. A population-based study on the incidence of dementia disorders between 85 and 88 years of age. J Am Geriatr Soc 44: 1455–1460 - PubMed
    1. Aisen PS, Cummings JL, Schneider LS 2011. Symptomatic and non-amyloid/Tau-based pharmacologic treatment for Alzheimer disease. Cold Spring Harb Perspect Med 10.1101/cshperspect.a006395 - PMC - PubMed
    1. Akbaraly TN, Portet F, Fustinoni S, Dartigues JF, Artero S, Rouaud O, Touchon J, Ritchie K, Berr C 2009. Leisure activities and the risk of dementia in the elderly: results from the Three-City Study. Neurology 73: 854–861 - PubMed
    1. Andersen K, Nielsen H, Lolk A, Andersen J, Becker I, Kragh-Sorensen P 1999. Incidence of very mild to severe dementia and Alzheimer’s disease in Denmark: The Odense Study. Neurology 52: 85–90 - PubMed
    1. Angevaren M, Aufdemkampe G, Verhaar H, Aleman A, Vanhees L 2008. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database of Systematic Reviews (Online): CD005381 - PubMed

MeSH terms